Riskreveal Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $13M

  • Investors
  • 1

Riskreveal General Information

Description

Developer of a genomic mutation detection technology designed to identify cancer and other disease-causing mutations from patient biopsy samples. The company's technology offers molecular stratification test and aggregates genomic information advances the understanding of etiology, and detects genomic mutations, providing oncologists with rapid, accurate and actionable information, enabling physicians to identify patients with IA-IIA non-squamous non-small cell lung cancer (NSCLC) who may be at low- or high risk of having a recurrence and treat their patients in an enhanced way.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 111 10th Avenue South
  • Suite 102, Room 123
  • Nashville, TN 37203
  • United States
+1 (844)
Primary Industry
Diagnostic Equipment
Parent Company
Dragon Scientific
Vertical(s)
Corporate Office
  • 111 10th Avenue South
  • Suite 102, Room 123
  • Nashville, TN 37203
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Riskreveal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 22-Feb-2023 $13M Completed Generating Revenue
5. Merger/Acquisition 25-Feb-2021 Completed Generating Revenue
4. Secondary Transaction - Private 05-Sep-2019 Completed Generating Revenue
3. Early Stage VC Completed Generating Revenue
2. Early Stage VC (Series A) 20-Jun-2016 $3.67M $4.37M Completed Generating Revenue
1. Seed Round 10-Jul-2014 $700K $700K Completed Generating Revenue
To view Riskreveal’s complete valuation and funding history, request access »

Riskreveal Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Riskreveal’s complete cap table history, request access »

Riskreveal Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genomic mutation detection technology designed to identify cancer and other disease-causing mutations fro
Diagnostic Equipment
Nashville, TN
4 As of 2016

San Diego, CA
 

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Riskreveal Competitors (25)

One of Riskreveal’s 25 competitors is Decipher Urologic Cancers, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Decipher Urologic Cancers Formerly VC-backed San Diego, CA
T2 Biosystems Formerly VC-backed Lexington, MA
CirculoGene Venture Capital-Backed Birmingham, AL
Foundation Medicine Formerly VC-backed Boston, MA
MultiplexDX Venture Capital-Backed Rockville, MD
You’re viewing 5 of 25 competitors. Get the full list »

Riskreveal Patents

Riskreveal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130059747-A1 Multigene prognostic assay for lung cancer Active 01-Jul-2011
US-9476098-B2 Multigene prognostic assay for lung cancer Active 01-Jul-2011

Riskreveal Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Riskreveal Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Foothill Ventures Venture Capital Minority
TSV Capital (Los Altos) Venture Capital Minority
UCSF Innovation Ventures Venture Capital Minority
Venture Leader Group Venture Capital Minority
To view Riskreveal’s complete investors history, request access »

Riskreveal FAQs

  • When was Riskreveal founded?

    Riskreveal was founded in 2014.

  • Where is Riskreveal headquartered?

    Riskreveal is headquartered in Nashville, TN.

  • What is the size of Riskreveal?

    Riskreveal has 4 total employees.

  • What industry is Riskreveal in?

    Riskreveal’s primary industry is Diagnostic Equipment.

  • Is Riskreveal a private or public company?

    Riskreveal is a Private company.

  • What is the current valuation of Riskreveal?

    The current valuation of Riskreveal is .

  • What is Riskreveal’s current revenue?

    The current revenue for Riskreveal is .

  • How much funding has Riskreveal raised over time?

    Riskreveal has raised $4.37M.

  • Who are Riskreveal’s investors?

    Foothill Ventures, TSV Capital (Los Altos), UCSF Innovation Ventures, and Venture Leader Group have invested in Riskreveal.

  • Who are Riskreveal’s competitors?

    Decipher Urologic Cancers, T2 Biosystems, CirculoGene, Foundation Medicine, and MultiplexDX are some of the 25 competitors of Riskreveal.

  • When was Riskreveal acquired?

    Riskreveal was acquired on 22-Feb-2023.

  • Who acquired Riskreveal?

    Riskreveal was acquired by Dragon Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process